Impact of chronic obstructive pulmonary disease on prognosis after percutaneous coronary intervention and bypass surgery for left main coronary artery disease: an analysis from the EXCEL trial | Zendy

Xin Huang | Zendy; Björn Redfors | Zendy; Shmuel Chen | Zendy; Yangbo Liu | Zendy; Ori BenYehuda | Zendy; John D. Puskas | Zendy; David E. Kandzari | Zendy; Béla Merkely | Zendy; Ferenc Horkay | Zendy; Ad J. van Boven | Zendy; Piet W. Boonstra | Zendy; Joseph F. Sabik | Zendy; Patrick W. Serruys | Zendy; A. Pieter Kappetein | Zendy; Gregg W. Stone | Zendy

Open Access

Impact of chronic obstructive pulmonary disease on prognosis after percutaneous coronary intervention and bypass surgery for left main coronary artery disease: an analysis from the EXCEL trial

Author(s) -

Xin Huang,

Björn Redfors,

Shmuel Chen,

Yangbo Liu,

Ori BenYehuda,

John D. Puskas,

David E. Kandzari,

Béla Merkely,

Ferenc Horkay,

Ad J. van Boven,

Piet W. Boonstra,

Joseph F. Sabik,

Patrick W. Serruys,

A. Pieter Kappetein,

Gregg W. Stone

Publication year - 2018

Publication title -

european journal of cardio-thoracic surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.303

H-Index - 133

eISSN - 1873-734X

pISSN - 1010-7940

DOI - 10.1093/ejcts/ezy438

Subject(s) - medicine , copd , percutaneous coronary intervention , conventional pci , cardiology , myocardial infarction , hazard ratio , revascularization , stroke (engine) , coronary artery disease , coronary artery bypass surgery , clinical endpoint , randomized controlled trial , artery , surgery , confidence interval , mechanical engineering , engineering

Percutaneous coronary intervention (PCI) is often favoured over coronary artery bypass grafting (CABG) surgery for revascularization in patients with chronic obstructive pulmonary disease (COPD). We studied whether COPD affected clinical outcomes according to revascularization in the Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial, in which PCI with everolimus-eluting stents was non-inferior to CABG for the treatment of patients with left main coronary artery disease and low or intermediate SYNTAX scores.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research